GSK's Garnier tells USA to arrange Massachusetts health coverage

23 April 2006

UK-based world number two drugmaker GlaxoSmithkline's chief executive, Jean-Pierre Garnier, has spoken out in favor of the US federal government providing universal health care coverage. The system he proposes would be modelled on the program recently approved in the state of Massachusetts, which includes provisions making it compulsory for most employers to provide health care insurance for their workforce.

Mr Garnier's comments come at a time when health care insurance coverage is a major political issue in the run-up to mid-term elections this November. He said: "essentially, everyone must have insurance; like car insurance, it becomes mandatory."

Meanwhile, John Sweeney, president of the AFL-CIO labor union federation, condemned the Massachusetts program for failing to provide coverage for employees in small businesses. He said that the decision by the State's Republican Governor, Mitt Romney, to veto the requirement for employer-provided coverage for businesses with as few as 10 employees, "sends the wrong message to other states looking for answers to their own health care crises."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight